The Wilms tumor gene, WT1, encodes a zinc-®nger DNA binding protein which is thought to function as a tissue speci®c transcription factor, regulating cell growth and dierentiation. High expression of WT1 has been detected in a range of acute leukemias. To elucidate a role for WT1 in leukemogenesis, we transfected the monoblastic cell line U937, which lacks detectable levels of endogenous WT1, with two isoforms of WT1. We showed that, in contrast to U937 control cells, cells constitutively expressing either of the isoforms, WT1(7KTS) or WT1(+KTS), did not respond to dierentiation induction by retinoic acid or vitamin D3, as judged by the capacity to reduce nitro blue tetrazolium and morphology. Although U937 cells expressing WT1 were hampered in their ability to dierentiate on incubation with retinoic acid and vitamin D3, the induced G1/G0-accumulation was similar to dierentiating control cells treated with inducers. Furthermore, distinct eects on the maturation process were indicated by downregulation of the myeloid cell surface makers CD13 and CD15, while the upregulation of CD14 and CD11c on WT1 transfected cells was similar to control cells upon incubation with retinoic acid and vitamin D3. Taken together our results demonstrate that a constitutive expression of WT1 in the leukemic cell line U937 leads to impairment of dierentiation responses, indicating that a high expression of WT1 can contribute to the dierentiation block of acute leukemia.
Introduction
Acute leukemia is characterized by an accumulation of immature cells, involving a dierentiation block in the normal hematopoiesis . The dierentiation block is often the result of inappropriate expression of transcription factors and subsequent disruption of the normal gene expression pattern (Shivdasani and Orkin, 1996) . In contrast to normal mature hematopoietic cells, cells of acute leukemia often express high levels of the zinc-®nger containing transcription factor Wilms' Tumor gene 1 (WT1) (Miwa et al., 1992) . The WT1 protein is mainly expressed in developing kidney, testis, ovary and spleen, indicating that it is involved in the differentiation processes of certain tissues (Call et al., 1990; Gessler et al., 1990; Pritchard-Jones et al., 1990) . Moreover, WT1 knock-out mice die before birth with failure of kidney and gonadal development (Kreidberg et al., 1993) .
The WT1 protein mediates transcriptional control of genes containing a GC-rich motif (5'-GCG GGGGGCG-3'), as well as a (TTC) n repeat in their promoter regions (Rauscher et al., 1990; Wang et al., 1993a) . Reported target genes for the WT1 protein include both genes involved in growth regulation and genes necessary for induction of dierentiation, such as c-myc, bcl-2 (Hewitt et al., 1995) , colony-stimulating factor-1 (CSF-1) (Harrington et al., 1993) , transforming growth factor-b1 (TGF-b1) (Dey et al., 1994) , insulin-like growth factor 1 receptor (IGF1R) (Werner et al., 1993) , insulin-like growth factor II (IGF II) (Drummond et al., 1992) , platelet-derived growth factor A-chain (PDGF-A) (Gashler et al., 1992) and retinoic acid receptor-a (RAR-a) (Goodyer et al., 1995) . The WT1 protein has been shown to mediate either transcriptional repression or activation, depending on the architecture of the promoter under study and the cell lines in which the transfection assay were performed (Madden et al., , 1993 Drummond et al., 1992; Maheswaran et al., 1993; Werner et al., 1993; Wang et al., 1993b) .
Four dierent isoforms of WT1, resulting from the combination of two alternative splices, have been observed in WT1-expressing cells (Haber et al., 1991) . Alternative splice I inserts 17 amino acids (+17AA) between the amino terminus and the zinc ®nger domains and alternative splice II introduces three amino acids (+KTS) between zinc ®ngers 3 and 4. The second alternative splice disrupts the spacing between two critical zinc ®nger domains, resulting in a narrower range of DNA target sequences and a binding of WT1(+KTS) to similar but not identical sequences as WT1(7KTS) (Drummond et al., 1994; Hewitt et al., 1996) . It has been proposed that WT1 containing the KTS insertion in addition to being a transcriptional regulator may play a role in posttranscriptional processing of RNA, since WT(+KTS) proteins colocalize and associate with proteins of the splicing machinery (Larsson et al., 1995) .
A role for WT1 in the dierentiation of hematopoietic cells has been suggested based on observations of high levels of WT1 mRNA and protein in several hematopoietic cell lines and, although at a lower level, also in CD34 + bonemarrow cells (Phelan et al., 1994; Sekiya et al., 1994; Fraizer et al., 1995; Baird and Simmons, 1997; Inoue et al., 1997) , while no expression of WT1 has been detected in peripheral blood cells. Thus, there seems to be an inverse correlation between WT1 expression and the degree of hematopoietic cell dierentiation. This is consistent with the ®nding that the expression of WT1 is downregulated during terminal dierentiation of some myeloid cell lines (Phelan et al., 1994; Sekiya et al., 1994) , suggesting that sustained high levels of WT1 are incompatible with dierentiation. Likewise, the expression of WT1 inversely correlates with the dierentiation level of acute leukemias (Patmasiriwat et al., 1996) . Furthermore, elevated WT1 expression in leukemia correlates with poor prognosis and quanti®cation of the WT1 gene expression has proven useful for monitoring minimal residual disease (MRD) in patients suering from acute leukemia (Inoue et al., 1994) .
The aim of the present work was to investigate the role of WT1 in leukemogenesis. As earlier reported (Baird and Simmons, 1997) , the monoblastic cell line U937 was found to lack detectable amounts of WT1 protein. Therefore, two isoforms of WT1 were stably transfected to U937 cells. Our results demonstrate that U937 cells with a constitutive expression of WT1 do not respond to dierentiation induction by retinoic acid or vitamin D3, indicating that a high expression of WT1 contributes to the dierentiation block of acute leukemia.
Results

Establishment and characterization of U937 clones constitutively expressing WT1
To investigate a role for WT1 in leukemic differentiation, stable clones of U937 cells expressing WT1 were established. Two isoforms, one lacking both the KTS and 17AA insertions (7KTS) and one with the KTS insertion (+KTS), were transfected into U937 cells by electroporation. Transfection of U937 cells with the 7KTS-isoform resulted in a number of clones growing under selecting conditions. When analysed for expression of WT1(7KTS) protein by biosynthetic labeling, three clones expressed the protein. These were designated WT1(7KTS)/C5, C10 and D12, respectively. The U937 cells were also transfected with the +KTS-isoform; two clones expressing this isoform of the WT1-protein arose and were designated WT1(+KTS)/B26 and B27. To obtain control clones, cells were transfected with empty vector (pCB6+). Two of these clones, growing under selective conditions were isolated and designated M1 and M2. The control clones did not express detectable levels of endogenous WT1 protein (Figure 1 ), con®rming previous observations on wild type U937 cells (Baird and Simmons, 1997) .
U937 clones expressing WT1 show similar growth rate and viability in suspension culture as control cells WT1 has been reported to in¯uence proliferation and viability of some cells Luo et al., 1995; Werner et al., 1995; Algar et al., 1996; Yamagami et al., 1996) . Therefore, we determined the growth rate in suspension culture of the WT1(7KTS) and WT1(+KTS) transfected cells. The cells were seeded in culture medium and cell number and viability were determined daily. No dierence in growth rate between WT1 transfectants and control cells was observed during 4 days of culture (Figure 2) . Viability of the cells, as judged by trypan blue exclusion, was also similar for WT1-transfectants and control cells and always more than 90% (data not shown). Thus, a constitutive expression of WT1 was compatible with unchanged growth rate and viability of U937 cells.
WT1 transfected U937 clones do not respond to induction of dierentiation by all-trans retinoic acid (ATRA) or vitamin D3 as judged by NBT-reduction U937 cells can be induced to terminal dierentiation by incubation with retinoic acid or vitamin D3, as judged by an increased fraction of cells reducing NBT, morphological changes and expression of monocyte surface antigens such as CD14 (Olsson and Breitman, 1982; Olsson et al., 1983; O È berg et al., 1993) . To determine the eects of a forced expression of Twenty-®ve to ®fty percent of U937 control cells showed NBT reducing capacity after 4 days of incubation with 10 mM ATRA (Figure 3 ). However, the WT1(7KTS)-and WT1(+KTS)-transfectants did not show capacity to reduce NBT under these conditions. Likewise, after incubation for 4 days with 0.1 mM vitamin D3 more than 90% of U937 control cells were able to reduce NBT, whereas less than 4% of the cells from the WT1(7KTS) or WT1(+KTS) transfected clones responded to vitamin D3 with induction of NBT reducing capacity ( Figure 3 ). These results demonstrate that constitutive expression of WT1(7KTS) or WT1(+KTS) in U937 cells conferred resistance to induction of dierentiation, as judged by NTB-reduction, by ATRA or vitamin D3.
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Figure 4 Morphological changes in response to ATRA or vitamin D3 of control cells and WT1 transfected cells. Cells at an initial concentration of 0.2610 6 cells/ml were incubated with or without 10 mM ATRA or 0.1 mM vitamin D3, as indicated. After 4 days cytospin slides were prepared and stained with May ± GruÈ nwald ± Giemsa and morphology was investigated with light microscopy. All photographs were taken at a magni®cation of 2506 using a Zeiss Axiophot 2 microscope small lobulated condensed nucleus with decreased number of nucleoli (Olsson and Breitman, 1982) . As expected, control cells showed these morphological characteristics when incubated with 10 mM ATRA for 4 days (Figure 4) . However, cells transfected with WT1(7KTS) or WT1(+KTS) did not respond with any morphological change (Figure 4) . Similarly, the mature phenotype observed in response to incubation with 0.1 mM vitamin D3 was not visible in WT1 transfected cells (Figure 4) . Thus, both capacity to reduce NBT and the morphological maturation were lacking in WT1-expressing cells upon incubation with ATRA and vitamin D3.
WT1 transfected cells undergo G1-arrest upon incubation with ATRA or vitamin D3
Normally, when cells are induced to terminal differentiation, they become growth arrested and accumulate in the G1/G0 phase of the cell cycle. To investigate the in¯uence of WT1-expression on the cell cycle distribution,¯ow cytometric analysis was performed. As expected, control cells accumulated in the G1/G0 phase after 3 days incubation with 10 mM ATRA and 0.1 mM vitamin D3 (Table 1) , while uninduced cells contained a larger fraction of cells remaining in S/G2, thus con®rming earlier data (O È berg et al., 1993) . However, also the WT1(7KTS)-and WT1(+KTS)-transfectants showed a similar accumulation in the G1/ G0 phase when incubated with inducers (Table 1 ). The accumulation of cells in G1/G0 phase, following incubation with ATRA or vitamin D3, was paralleled by a decline in proliferation rate ( Figure 5 ). Again, no dierence was observed between control cells and transfectants, although WT1(+KTS) transfected cells incubated with ATRA showed a slightly lower viability as compared to control cells or WT1(7KTS) transfected cells (legend Figure 5) . Thus, even though the WT1 transfected cells do not respond with dierentiation, as judged by NBT-reduction and morphology ( Figures 3 and 4) , these cells respond with G1-arrest similar to control cells upon incubation with ATRA and vitamin D3.
WT1 transfected cells upregulate some monocyte related cell surface antigens upon incubation with ATRA and vitamin D3
A number of cell surface antigens are known to be upregulated when U937 cells are induced for differentiation. These antigens can be used as markers for dierentiation as a complement to the NBT-reducing capacity, which is a functional marker, and morphology. The expression of CD14, CD11c, CD13 and CD15 was monitored on control cells and WT1 transfectants by¯ow cytometric analysis after incubation with or without inducers. The expression of CD14 (receptor for lipopolysaccharide) (Wright et al., 1990) can be induced on U937 by vitamin D3 (O È berg et al., 1993) . Likewise CD11c (CD11c/CD18, p150, 95) (Carlos and Harlan, 1994 ) is upregulated on U937 in response to vitamin D3 or ATRA (O È berg et al., 1993) . CD13 (gp 150, aminopeptidase N) and CD15 (LeX) are markers for myeloid cells (Look et al., 1989; Stocks et al., 1990) . Cells at an initial concentration of 0.2610 6 cells/ml were incubated with 10 mM ATRA and 0.1 mM vitamin D3. As shown in Table 2 , control cells and WT1 transfected cells showed a low and moderate expression of CD14 and CD11c, respectively. As expected, CD11c was upregulated in control cells in response to both ATRA and vitamin D3, and CD14 was upregulated in response to vitamin D3. However, also WT1(7KTS) and WT1(+KTS) expressing cells showed increased expression of CD14 and CD11c when incubated with the dierentiation inducing agents. The high expression levels of CD13 and CD15 of uninduced control cells (Figure 6a) were sustained during incubation with vitamin D3 and ATRA (data not shown). In contrast, CD13 and CD15 levels were low in WT1(7KTS) and WT1(+KTS) transfected cells (Figure 6b,c) , as compared to control cells, and remained low during incubation with ATRA and vitamin D3 (data not shown). Our observations demonstrate that the response of CD14 and CD11c to ATRA or vitamin D3 was preserved in WT1 transfected cells, indicating that the dierentiation block in WT1-expressing cells was not complete.
Discussion
The aim of the present study was to test the hypothesis that expression of WT1 contributes to the differentiation block in leukemic cells. To this end we utilized the U937 cell line, which lacks endogenous expression of WT1 and can be induced to terminal dierentiation in vitro. By establishing stable transfectants, we were able to demonstrate that U937 clones constitutively expressing either of two isoforms of WT1, 7KTS or +KTS, were unable to respond to dierentiation induction by retinoic acid or vitamin D3. This conclusion is based on the observation that transfected cells, as opposed to control cells, did not acquire a mature phenotype as judged by functional criteria (NBT-reduction) and morphology. Thus, constitutive expression of WT1 can contribute to a dierentiation block, a characteristic of acute leukemia. From correlative data it is suggested that WT1 may counteract maturation. Thus, the WT1 expression levels inversely correlate with the dierentiation stage of hematopoietic cells (Patmasiriwat et al., 1996) ; cells of many acute leukemias demonstrate high expression levels of WT1 (Miwa et al., 1992) ; CD34+ cells show high levels of WT1 (Fraizer et al., 1995; Patmasiriwat et al., 1996; Baird and Simmons, 1997) , and WT1 is downregulated in some cell lines during induced terminal dierentiation (Phelan et al., 1994; Sekiya et al., 1994) . The present report is the ®rst to demonstrate that constitutive expression of WT1 in leukemic cell lines can lead to impairment of some dierentiation responses, suggesting that downregulation of WT1 indeed may be a prerequisite for terminal differentiation. Cells were incubated at an initial concentration of 0.2610 6 cells/ml with 10 mATRA or 0.1 mM vitamin D3. After 4 days the cells were subjected to analysis of surface antigens. Values shown are percentage of cells expressing surface antigens. One representative experiment out of three performed is shown WT1 antisense oligomers inhibit the cell growth of both leukemic cell lines and fresh leukemic cells from patients with acute or chronic myeloid leukemia, but not normal colony-forming-unit granulocyte-macrophage (CFU-GM) (Algar et al., 1996; Yamagami et al., 1996) . This indicates that the WT1 protein may be important for the sustained proliferation of leukemic cells. The U937 cells stably transfected with the two isoforms of WT1(7KTS or +KTS), did not dier in growth rate in suspension culture as compared to control cells. However, this observation is not contradictory to a growth promoting eect of WT1, since it would be dicult to demonstrate this property of WT1 in a transformed cell line that is already maximally dividing. In contrast to the indicated proliferative eect in leukemic cells, overexpression of WT1 has been shown to suppress growth of other cell lines from several types of tissues Werner et al., 1995; Luo et al., 1995) . The present results demonstrate that U937 cells transfected with WT1 were unaected with respect to growth rate as compared to control cells, indicating that the WT1 protein conferred no negative cell cycle control in these cells. However, growth inhibitory eects from the WT1 protein might be selected against during the establishment of stable cell clones and might therefore not be evident. Hypothetically, analogous selection might take place in the development of acute leukemia.
It has been postulated that, in general, an arrest at the G1-phase of the cell cycle increases the probability for dierentiation, and terminal dierentiation is characterized by an accumulation of the cells in G1/ G0 (Pardee, 1989) . This has also been observed in U937 cells, which are arrested in G1/G0 upon treatment with retinoic acid or vitamin D3 (O È berg et al., 1993) . Therefore growth arrest and accumulation of cells in G1/G0 might be considered as one marker for terminal dierentiation. As discussed above, the WT1-transfectants did not respond to induction with either retinoic acid or vitamin D3, as judged by both functional and morphological criteria. Accordingly, we expected that WT1 transfected cells would show less tendency for exit from the cell cycle, as compared to control cells, when incubated with dierentiation inducers. However in spite of a lack of differentiation, the cells still accumulated in the G1/G0-phase of the cell cycle. Thus, our data indicate that differentiation and proliferation can be separately regulated, and that WT1 primarily interferes with other parts of the dierentiation process than cell cycle regulation. Distinct eects of WT1 on the maturation process is further indicated by the results from analysis of cell surface antigens; while CD13 and CD15 were downregulated in transfected cells and also did not respond to dierentiation induction, the responses of CD11c and CD14 to ATRA or vitamin D3 were apparently unaected. The induction of CD14 in response to vitamin D3 is an early event, maximal after 24 h (O È berg et al., 1993) , while the appearance of the capacity to reduce NBT is a later event (Olsson and Breitman, 1982) . This suggests that the dierentiation block in WT1-transfected cells involves late stages in the dierentiation response. However, also the induction of CD11c, which normally is a late response to dierentiation induction with ATRA or vitamin D3 (O È berg et al., 1993) , was preserved in U937 cells expressing WT1. Therefore it seems more likely that the impaired maturation of WT1-transfectants is due to interference with distinct signaling pathways during ATRA or vitamin D3 induced dierentiation.
What is the mechanism for the dierentiation block of U937 cells caused by WT1? As discussed above, impairment of the cell cycle regulation does not seem to be the main mechanism. A few other possibilities can, however, be outlined; the obvious one being that many genes, encoding proteins important for differentiation, have a WT1 binding sequence in their promoter region and therefore their expression can be dysregulated by WT1. However, also genes not directly regulated by WT1 might be involved, since a selection against hypothetical negative eects of WT1 on proliferation might have occurred during establishment of the cell clones, resulting in distinct genetic changes.
We show that WT1(7KTS) and WT1(+KTS) transfected cells are equally hampered in their ability to respond to dierentiation signals, implying that both forms can be involved in the dierentiation block of acute leukemia. WT1(+KTS) may have a role in posttranscriptional processing of RNA rather than being a transcriptional regulator (Larsson et al., 1995) . Therefore, the ability of WT1(+KTS) to exert posttranscriptional regulation could also be important in the dierentiation process of hematopoietic cells. Another possible mechanism is that WT1 directly binds to and changes the function of other proteins that regulate cell growth and differentiation. This could be analogous to the physical and functional interaction between the WT1 protein and p53 shown in transactivation assays . The WT1 protein enhances transcriptional activity of p53, while wild-type p53 appears to convert WT1 from a transcriptional activator to a transcriptional repressor. It has also been reported that the WT1 protein has the ability to stabilise p53 and inhibit p53-mediated apoptosis . Leukemic cells often express intact p53, while U937 cells lack detectable amounts of normal p53 (Sugimoto et al., 1992) . Therefore it is not, from our data, possible to judge the eect of WT1 on p53-mediated toxicity. It remains to be determined whether interaction between p53 and WT1 plays an important role in acute leukemia. In contrast to control cells or WT1(7KTS) transfected cells, WT1(+KTS) transfected cells showed a slight, but reproducible, tendency for cell death upon incubation with ATRA. Thus the present results suggest that, rather than protecting from apoptosis, the WT1 protein can render the cells more sensitive to apoptosis. This observation is similar to what has been reported for F9-cells, constitutively expressing WT1, which respond with apoptotic death in response to retinoic acid . No increased cell death was observed upon incubation with vitamin D3, which is consistent with the previously reported protection against cell death of U937 cell by this vitamin .
In conclusion, the present results demonstrate that a constitutive expression of WT1 in U937 leukemic cells abrogates the dierentiation response to retinoic acid or vitamin D3, indicating that WT1 can be important for the dierentiation block of acute leukemia.
Materials and methods
Cell culture
The human monoblastic cell line U937-4 (SundstroÈ m and Nilsson, 1976; Olsson et al., 1983) was cultured in RPMI 1640 (Gibco Ltd, Paisley, UK) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Gibco Ltd) in a humidi®ed 5% CO 2 -atmosphere at 378C. Exponentially growing cells were used for all experiments.
Vector constructs
The eukaryotic expression vectors pCMV-CB6 + (Brewer, 1994) carrying the cDNA for WT1(7KTS) (pCB6 + -WT1 8A) and WT1(+KTS) (pCB6 + -WT1+KTS) Morris et al., 1991) . pCMV-CB6 + provides a cytomegalovirus (CMV) promoter-driven expression of WT1(7KTS) or WT1(+KTS) and also confers resistance to geneticin allowing selection of recombinant cells.
Transfection procedure
Before transfection, plasmids were linearized with restriction enzyme Alw 44i to facilitate integration of vectors into the genome. U937 cells were resuspended in culture medium (RPMI 1640+10% FCS) at a concentration of 1610 7 cells/ml. Twenty-®ve mg of plasmid was added to 0.4 ml of cell suspension and introduced into the cells by electroporation using the Bio-Rad genepulser (Bio-Rad, Hercules, CA) with a capacitance setting of 960 mF and a voltage setting of 260 V. After electroporation, cells were incubated at room temperature for 10 min, then transferred to fresh culture medium at a concentration of 0.4610 6 cells/ml and incubated at 378C. After 48 h, the electroporated cells were distributed in 96-well plates at 5000 cells/well. After 3 weeks, individual clones growing in the presence of geneticin (1.5 mg/ml) (Boehringer Mannheim, Mannheim, Germany) were expanded to mass cultures and assayed for WT1-expression. (Ehinger et al., 1995) . Brie¯y, cells were harvested at exponential growth and incubated for 30 min at 378C in methionine-and cysteine-free RMPI 1640 (Gibco Ltd) supplemented with 10% dialyzed FCS (Gibco Ltd) in order to deplete the intracellular pools of methionine and cysteine. Subsequently, the cells were incubated for 2 h at 378C in the same medium supplemented with [
Biosynthetic labeling, immunoprecipitation, electrophoresis and uorography
35 S]methionine/ [ 35 S]cysteine. Labeled WT1 protein was immunoprecipitated with 10 mg of rabbit polyclonal anti-human WT1 IgG (WTC-19, Santa Cruz Biotechnology, Santa Cruz, CA), whereupon the immunoprecipitates were subjected to SDS ± PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) followed by¯uorography as described (Ehinger et al., 1995) .
Determination of growth rate in suspension culture
Cells at an initial concentration of 0.2610 6 cells/ml were grown in suspension culture and the number of cells was judged by daily counting in BuÈ rker-chamber. The viability was determined by trypan blue exclusion.
Assessment of dierentiation by the nitro blue tetrazolium (NBT) reduction test
Cells (0.2610 6 cells/ml) were incubated with 1-a-25-dihydroxycholecalciferol (Vitamin D3) (a generous gift from Roche, Basel, Switzerland) or all-trans retinoic acid (ATRA) (SIGMA Chemical Co, St Louis, MO) for 4 days. At harvest, cells were resuspended at a concentration of 1 ± 2610 6 cells/ml and incubated for 25 min at 378C in RPMI 1640 supplemented with 20% FCS containing 0.075% (w/v) NBT (nitro blue tetrazolium) (SIGMA) and 0.15 mg/ ml PMA (phorbol-12-myristrate-13 acetate) (SIGMA). Cytospin slides were prepared and stained with May ± GruÈ nwald ± Giemsa. The percentage of cells containing formazan deposits, corresponding to the capacity to reduce NBT, was determined by counting 200 cells.
Assessment of dierentiation by morphological analysis
Cells were incubated with or without inducers for 4 days, and then cytospin slides were prepared and stained with May ± GruÈ nwald ± Giemsa. Morphology was characterized by light microscopy.
Determination of cell cycle distribution by¯ow cytometric DNA analysis
Control cells and transfected cells were incubated with or without inducers and subjected to analysis of cell cycle distribution after 3 days. Staining of nuclei and¯ow cytometric analysis were performed as previously described (Baldetorp et al., 1989 (Baldetorp et al., , 1992 . Brie¯y, for staining of nuclei, cells were washed in PBS (phosphate buer saline), whereupon nuclei isolation medium containing propidium iodide was added. Samples were incubated in the dark for 5 min at room temperature. Then, samples were kept at 48C for at least 15 min before¯ow cytometric analysis was performed in an Ortho-Cytoron Absolute (Ortho Diagnostic Systems, Raritan, NJ) equipped with a 15 mW argon ion laser. The laser line at 488 nm was used for excitation of propidium iodide and the¯uorescence beyond 620 nm was detected. Up to 20 000 nuclei per sample were analysed. Processor signals were digitized and sorted into frequency distributions (DNA histograms) with a resolution of 256 units. Cell cycle phase distribution i.e. the percentages of G0+G1, S and G2 nuclei of the analysed cell population was determined by applying Multi Cycle 1 (Phoenix Flow Systems, Tucson, AZ) on the DNA histograms. The DNA histograms were corrected for contribution of nucleic debris.
Assessment of cell surface antigens by¯ow cytometric analysis
Cells were washed in PBS and resuspended to 5 ± 10610 7 cells/ml. Fifty ml of the cell suspension was incubated with 5 ml of the following monoclonal antibodies in microtiter wells: control IgG1-FITC/IgG1-PE, CD14-PE, CD11c-PE (Becton Dickinson, San JoseÂ , CA), CD13-PE and CD15-FITC (DAKO A/S, Copenhagen, Denmark), for 10 min at room temperature under constant agitation. The cells were then washed three times and ®xed in 1% paraformaldehyde before¯ow cytometric analysis (FACScan, Becton Dickinson). Ten thousand cells were collected for each antibody. Dead cells and debris were excluded from analysis by gating prior to the calculation of the percentage of positive cells, using the control incubation with IgG1-FITC/IgG1-PE for marker settings.
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